US FDA: Pharmaceutical Distribution Entering DSCSA Compliance ‘Stabilization Period’

 
• By Bowman Cox
  
Pharmaceutical manufacturing in the abstract
time to smooth out package-level tracing • Source: Shutterstock

More from Distribution/Supply Chain

More from Compliance